NextCure, Inc.
NXTC
$0.428
-$0.0166-3.73%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 5.40% | -0.55% | 25.08% | 9.95% | -18.25% |
| Total Depreciation and Amortization | -2.97% | -3.71% | -0.14% | -11.27% | -4.13% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -7.78% | 3.07% | -5.86% | -57.40% | 84.06% |
| Change in Net Operating Assets | -252.42% | 232.70% | -155.50% | 811.69% | -66.98% |
| Cash from Operations | -86.45% | 39.16% | -17.16% | 22.45% | -18.14% |
| Capital Expenditure | -- | 120.00% | 43.52% | -713.51% | -184.62% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 2.46% | -62.53% | 48.28% | -30.46% | 329.17% |
| Cash from Investing | 1.95% | -61.99% | 50.55% | -31.99% | 329.63% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | 3,500.00% | -99.06% | 10,500.00% | -98.59% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | 3,500.00% | -99.06% | 10,500.00% | -98.59% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -23,700.00% | -99.64% | 175.26% | -52.81% | 181.96% |